HC Wainwright reiterated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $32.00 target price on the stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com cut shares of Kura Oncology […]